Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Inhibition of heat-shock protein 90 reduces Ebola virus replication
Darci R. Smith
, Sarah McCarthy
, Andrew Chrovian
,
Gene Olinger
, Andrea Stossel
,
Thomas W. Geisbert
, Lisa E. Hensley
, John H. Connor
Research output
:
Contribution to journal
›
Article
›
peer-review
99
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of heat-shock protein 90 reduces Ebola virus replication'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Virus Replication
100%
Ebola Virus
100%
Heat Shock Protein 90 (Hsp90)
100%
Heat Shock Protein 90 Inhibitor
80%
Host Factors
40%
Effective Concentration
40%
Geldanamycin
40%
Virus
20%
Viral Replication
20%
Hemorrhagic Fever
20%
Mandatory Vaccines
20%
High Mortality Rate
20%
Filovirus
20%
Zaire Ebolavirus
20%
Negative-sense RNA Virus
20%
Filoviridae
20%
Negative-strand
20%
Therapeutic Treatment
20%
Primates
20%
Ebola Virus Infection
20%
Primary Monocytes
20%
Molecular Chaperone
20%
17-allylamino-17-demethoxygeldanamycin
20%
Radicicol
20%
Immunology and Microbiology
Viral Replication
100%
Ebola Virus
100%
Heat Shock
100%
Replication
62%
Host Factor
25%
Effective Concentration
25%
Viral Disease
12%
Mortality Rate
12%
Hemorrhagic Fever
12%
Filovirus
12%
Negative-Strand RNA Virus
12%
Filoviridae
12%
Virus
12%
Chaperone Protein
12%
Infection
12%
Biochemistry, Genetics and Molecular Biology
Virus Replication
100%
Ebolavirus
100%
Heat Shock Protein
100%
Heat Shock Protein 90 Inhibitor
57%
Effective Concentration
28%
Geldanamycin
28%
Filovirus
14%
Mortality Rate
14%
Negative-Strand RNA Virus
14%
Filoviridae
14%
Radicicol
14%
Chaperone Protein
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ebola Virus
100%
Heat Shock Protein 90
100%
Heat Shock Protein 90 Inhibitor
57%
Host Factor
28%
Geldanamycin
28%
Infection
14%
Mortality Rate
14%
Hemorrhagic Fever
14%
Virus Infection
14%
Filoviridae
14%
Filovirus
14%
Negative-Strand RNA Virus
14%
Chaperone
14%
Tanespimycin
14%
Radicicol
14%